Quote:
Originally Posted by martyh
The only thing i see is mass hysteria and paranoia.This proposal could be a valuable tool in the developement of new drugs.Yes safeguards should be in place to prevent abuse and i'm sure they will be but paranoia shouldn't prevent the developement of such a scheme
|
Actually dont see how personally as too much data information make it harder. Said pharmasuticals already have trials data past on IF THEY request it but only given if the patient and specialist or GP put that patient forward. I have in the past done so when new drugs for my health my GP asked if minded I said no. I then had to be checked very regularly vitals etc had to keep log.
They can therefore get the required information through proper channels. they dont need to buy it cannot understand why this policy needed.
The fact also we in climate at moment where research and developments in the pharmasutical industry being pegged back or even scrapped.
So dont see how this going to benefit this area at all.